Pharmacological and biological basis of drug hypersensitivities;Bases pharmacologiques et biologiques des allergies medicamenteuses

Therapie

Volumn 55, Issue 1, 2000, Pages 7-12

  Albengres, E ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Drug hypersensitivity; Immune response; In vitro diagnosis

Indexed keywords

ANTIGEN; DRUG;

ANTIGEN RECOGNITION; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DRUG HYPERSENSITIVITY; DRUG SENSITIZATION; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOSTIMULATION; METHODOLOGY; PRIORITY JOURNAL; SYMPTOM;

ANIMALS; DRUG HYPERSENSITIVITY; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 0034110876     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Albengres E, Urien S, Riant P et al. Binding of two antranilic acid derivatives to human albumin, erythrocytes and lipoproteins: evidence for glalenic acid high affinity binding. Mol Pharmacol 1986; 31: 294-300.
2. Smith PC, McDonagh AF, Benet LZ. Irreversible binding of zomepirac to plasma protein in vitro and in vivo. J Clin Invest 1986; 77: 934-939.
3. Smith PC, Benet LZ, McDonagh AF. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. Drug Metab Dispos 1990; 18: 639-644.
4. Benet LZ, Spahn-Langguth J, Ojingwa JC et al. Covalent binding of drugs to albumin: experimental mechanisms and pharmacological significance. In: Tillement JP, Eckert Helmut, eds. Blood Binding & Drug Transfer. Paris: Fort et Clair Publishing Co, 1993: 13-29.
5. Zia-Amirhoeini P, Ding A, Burlingame AL et al. Synthesis and mass-spectrometric characterization of human serum albumins modified by covalent binding of two non-steroidal anti-inflammatory drugs: tolmetin and zomepirac. Biochem J 1995; 311: 312-315.
6. Gut J, Christen U, Huwyler J. Mechanisms of halothane toxicity. Novel insights. Pharmac Ther 1993; 58: 133-155.
7. Schnyder B, Mauri-Hellweg D, Zanni M et al. Direct MHC-dependent presentation of drug sulfomethoxazole to human alphabeta T cell clones. J Clin Invest 1997; 100: 136-141.
8. Atkinson NF, Mardiney M Jr, Wheeler B. The induction and persistence of penicilloyl antibodies in Man. In: Esteabrook RW, Lindenlaub E, Oesch F, de Weck AL eds. Toxicological and Immunological Aspects of Drug Metabolism and Environmental Chemicals. Stuttgart/New York: FK Schattauer Verlag: 397-411.
9. Noma T, Yashisawa I, Maeda K, Ichikavva K et al. Allergen-specific induction of interleukin 2 (IL2) responsiveness in lymphocytes from children with asthma. J Allergy Clin Immunol 1989; 84: 250-262.
10. Stavnezer J. Antibody class switching. Adv Immunol 1996; 61: 79-146.
11. Hershey GK, Friedrich MF, Esswein LA et al. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N Engl J Med 1997; 337: 1720-1726.
12. Wills-Karp M, Luyimbazi J, Xueying Xu et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282: 2258-2261.
13. Homberg JC, Stelly N, Andreis I el al. A new anti-mitochondria antibody (anti-M6) in iproniazid-induced hepatitis. Clin Exp Immunol 1982; 47: 93-102.
14. Homberg JC, Andre C, Abuaf N. A new-anti-liver-kidney microsome antiody (anti LKM2) in tienilic cid-induced hepatitis. Clin Exp Immunol 1984; 55: 561-570.
15. Boccaccio F, Attali P, Natal J et al. Acute hepatitis caused by dihydralazine. Gastroenterol Clin Biol 1987; 11: 614.
16. Pons C, Dansette PM, Gregeois J et al. Human anti-mitochondria autoantibodies appearing in iproniazid-induced immunoallergic hepatitis recognize human liver monoamine oxydase B. Biochem Biophys Res Com 1996; 218: 118-124.
17. Laroche D, Vergnaud MC, Sillard B et al. Biochemical markers of anaphylactoid reactions to drugs. Anesthesiology 1991; 75: 945-949.
18. Clerici M, Landay AL, Kessler HA et al. Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients. J Infect Dis 1992; 166: 723-730.
19. Li TS, Tubiana R, Katlama C, Calvez V et al. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351: 1682-1686.
20. Tubiana R, Carcelain G, Mohand HA, Li TS et al. Immunologic reconstruction after antiretroviral treatment. Presse Med 1999; 28: 424-428.
21. Spira Md, Jones BM, Nicholson JKA et al. Idiopathic CD4+ T-lymphocytopenia. An analysis of five patients with unexplained opportunistic infections. N Engl J Med 1993; 328: 386-392.
22. Hubert P, Bergeron F, Grenot P et al. Anomalies de la voie de signalisation CD3-TCR chez trois patients atteints de lymphopénie CD4+ idiopathique. J Sor Biol 1999; 193: 11-16.
23. Brattig NW, Dia GJ, Berg PA. The specificity of the lymphocyte transformation test in a patient with hypersensitive reactions to pyrazolone compounds. A 10 week follow-up study before and after rechallenge. Eur J Clin Pharmacol 1988; 35: 39-45.
24. Escaut L, Liotier Y, Albengres E et al. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction. AIDS 1999; 13: 17-18.
25. Tsutsui H, Terano Y, Sakagami C et al. Drug-specific T-cells derived from patients with drug-induced allergic hepatitis. J Immunol 1992; 149: 706-716.
26. Maria VAJ, Pinto L, Victorino RMM. Lymphocyte reactivity to ex-vivo drug antigen in drug-induced hepatitis. J Hepatol 1994; 21: 151-158.